Snackable Health® with Dr. Gibson and Dr. Kohli: Breast density. What does it mean for women? How do you know if your breast is dense? How does that inform your follow-up? October 12, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Is the COVID-19 pandemic finally over? Dr. Payal Kohli and I discuss President Biden’s statement October 12, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: There is an underdiagnosis of mental health conditions in the US. Will the newly published changes in the recommendations of anxiety screening help with this issue? October 12, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: 4 out of 5 maternal deaths are preventable. Dr. Payal Kohli and I discuss this alarming statistic October 12, 2022 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2022 Daily Wrap-Up – September 19, 2022 September 19, 2022 Disclosure: TBA
Dr. Pablo Salinas and Dr. Yazan Daaboul Discuss: Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial September 19, 2022 Disclosure: TBA
Dr. Toshiro Shinke and Dr. C. Michael Gibson Discuss: Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry) September 19, 2022 Disclosure: TBA
Dr. Antonio Mangieri and Dr. C. Michael Gibson Discuss: Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial September 19, 2022 Disclosure: TBA
Dr. Shamir Mehta and Dr. C. Michael Gibson Discuss: Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction September 19, 2022 Disclosure: TBA
Dr. Lei Song and Dr. C. Michael Gibson Discuss: Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial September 19, 2022 Disclosure: TBA
